ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

AFMD Affimed NV

5.30
-0.03 (-0.56%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Affimed NV AFMD 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.03 -0.56% 5.30 08:24:28
개장가 저가 고가 종가 전일 종가
5.47 5.21 5.4799 5.30 5.33
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202417:05GLOBEAffimed Announces Acceptance of AFM24 Clinical Abstract at..
28/03/202419:30GLOBEAffimed Reports 2023 Financial Results and Operational..
21/03/202419:30GLOBEAffimed To Report Full Year 2023 Financial Results &..
12/03/202405:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/03/202420:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/03/202420:30GLOBEAffimed Announces 1-for-10 Reverse Stock Split
09/01/202406:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/01/202406:05GLOBEAffimed Provides Clinical Response Update on AFM24-102 Trial..
08/01/202422:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/01/202422:00GLOBEAffimed Announces Leadership Change and Organizational..
03/01/202420:30GLOBEAffimed Announces Sale of Wholly-Owned Subsidiary AbCheck
11/12/202320:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202320:02GLOBEAffimed Announces Positive Data for AFM24 in Combination..
11/12/202320:00GLOBEAffimed Announces Updated Phase 1/2 Data from Acimtamig in..
04/12/202320:30GLOBEAffimed to Host Investor Conference Call Highlighting..
30/11/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202320:30GLOBEAffimed Reports Third Quarter 2023 Financial Results and..
09/11/202320:30GLOBEAffimed Announces Acimtamig as International Nonproprietary..
07/11/202320:30GLOBEAffimed to Report Third Quarter 2023 Financial Results &..
04/11/202301:05GLOBEAffimed Presents Preclinical Data Showing that Addition of..
02/11/202322:05GLOBEAffimed Announces Oral Presentation of Phase 1/2 Data from..
01/11/202319:30GLOBEAffimed to Participate in Upcoming Investor Conferences
04/10/202319:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202319:30GLOBEAffimed Announces Listing Transfer to Nasdaq Capital Markets
27/09/202322:05GLOBEAffimed Announces Acceptance of an Abstract Comparing NK..
21/09/202319:30GLOBEAffimed to Present at the Cantor Global Healthcare..
12/09/202319:30GLOBEAffimed Receives FDA Fast Track Designation for AFM13 in..
07/09/202319:30GLOBEAffimed to Present at the H.C. Wainwright Annual Global..
22/08/202318:00GLOBEAffimed Announces Publication in the Journal mAbs on..
10/08/202319:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/08/202319:30GLOBEAffimed Reports Second Quarter 2023 Financial Results and..
03/08/202319:30GLOBEAffimed to Report Second Quarter 2023 Financial Results..
01/08/202306:05GLOBEAffimed Announces an ASCO Breakthrough Poster Presentation..
22/06/202319:30GLOBEAffimed Announces Addition of Dr. Constanze Ulmer-Eilfort to..
10/06/202306:59GLOBEAffimed Announces Acceptance of Abstracts at the 17th..
03/06/202322:00GLOBEAffimed Presents AFM24 Monotherapy Data in Non-Small Cell..
30/05/202319:30GLOBEAffimed to Present at the 2023 Jefferies Healthcare..
26/05/202306:00GLOBEAffimed Announces Publication of AFM24 Clinical Abstracts..
23/05/202319:30GLOBEAffimed Reports First Quarter 2023 Financial Results and..
23/05/202319:15GLOBEAffimed Announces IND Clearance for a Phase 2 Clinical Trial..
22/05/202319:30GLOBEAffimed Announces Annual General Meeting of Shareholders
16/05/202319:30GLOBEAffimed to Report First Quarter 2023 Financial Results &..
11/05/202323:05GLOBEAffimed Announces Abstracts at the Annual Meeting of the..

최근 히스토리

Delayed Upgrade Clock